Anti-Coagulation Therapy with Impella Heparin Infusion
Using a defined cardiogenic shock best practices protocol derived from real-world data for cardiogenic shock treatment has been associated with improved outcomes. Download this cardiogenic shock guidelines pocket guide, offering best practices derived from the Abiomed Impella® Quality (IQ) Assurance Program and IRB-approved cVAD Study including, minimizing exposure to toxic inotropic medicines, unloading the left … Continue reading “Cardiogenic Shock Protocol Pocket Guide”
The Impella CP is approved for use in high-risk percutaneous coronary intervention and cardiogenic shock and are proven to unload theleft ventricle and support the systemic circulation.¹ Having the opportunity to rest the left ventricle has proven to increase heart recovery while keeping other therapeutic options open. The Impella CP heart pump may provide these … Continue reading “Impella CP® Step-By-Step Left Heart Unloading Poster”
Download the Allegheny Health Network Protected PCI Algorithm to guide decision-making for appropriate use of the Impella® heart pump for Protected PCI.
New data from the National Cardiogenic Shock Initiative Study (NCSI) on 171 consecutive AMI cardiogenic shock (AMICS) patients from 35 sites demonstrates 72% survival with 98% native heart recovery at discharge. The patients were treated with the NCSI protocol, which includes placing the Impella heart pump before revascularization. The study demonstrates the protocol-based approach to … Continue reading “New Data from NCSI Demonstrates 72% Survival with 98% Native Heart Recovery”
Committed to improving outcomes in Cardiogenic Shock and Protected PCI through excellence in education.
Use this patient transfer checklist and documentation when transferring a patient supported with an Impella® device from the “Spoke” hospital to the “Hub” hospital. Completing the patient transfer checklist ensures the best possible outcome for the patient during the transfer process.
A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance Database and physician-initiated National Cardiogenic Shock Initiative support the recommendation that placing Impella 2.5 or Impella CP pre-PCI improves outcomes.
Use this FDA-approved checklist to guide treatment decisions and determine if the Impella RP is right for your patients. IMP-574